NLRP3 and Alzheimer disease: Indeed, given the lack of effective drugs in the therapy of neurodegenerative conditions and the likely role of the NLRP3 inflammasome in the pathogenesis and progression of AD, efforts should be made to develop effective therapeutic strategies targeting the NLRP3 inflammasome.